Parallel Trade: Switzerland, The EU, And The US - International Society For Pharmacoeconomics And Outcomes Research

Parallel Trade of pharmaceutical products has become a common phenomenon in many parts of the world, with significant impact on the healthcare systems of the countries involved. An overview of the status quo of parallel trade of pharmaceuticals was performed to investigate its economic, political and legal background as well as to assess its consequences on research, public health, and health care financing.

More: continued here

Filed under: Pharma Industry on May 22nd, 2008